MAPT and Alzheimer disease: MiRNAs affect diverse physiological and pathological aspects of brain health and diseases such as AD, by controlling the expression of genes related to Aβ formation, tau phosphorylation, neuroinflammation, synaptic plasticity, and neuronal viability [270–273].